Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_assertion type Assertion NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_head.
- NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_assertion description "[Low activity of arylamine N-acetyltransferase 2 (slow NAT2) was consistently associated with urinary bladder cancer risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_provenance.
- NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_assertion evidence source_evidence_literature NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_provenance.
- NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_assertion SIO_000772 10022251 NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_provenance.
- NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_assertion wasDerivedFrom befree-2016 NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_provenance.
- NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_assertion wasGeneratedBy ECO_0000203 NP245624.RAslsMZ7460b7LUoOqQGdYhZLG2V7f_V0D27r21Abpohw130_provenance.